167 related articles for article (PubMed ID: 11821176)
1. In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa.
Pendland SL; Messick CR; Jung R
Diagn Microbiol Infect Dis; 2002 Jan; 42(1):75-8. PubMed ID: 11821176
[TBL] [Abstract][Full Text] [Related]
2. In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.
Flynn CM; Johnson DM; Jones RN
J Chemother; 1996 Dec; 8(6):411-5. PubMed ID: 8981179
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.
Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1995 Nov; 39(11):2503-10. PubMed ID: 8585734
[TBL] [Abstract][Full Text] [Related]
4. Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa.
Burgess DS; Nathisuwan S
Diagn Microbiol Infect Dis; 2002 Sep; 44(1):35-41. PubMed ID: 12376029
[TBL] [Abstract][Full Text] [Related]
5. Timed killing kinetic studies of the interaction between ciprofloxacin and beta-lactams against gram-negative bacilli.
Pohlman JK; Knapp CC; Ludwig MD; Washington JA
Diagn Microbiol Infect Dis; 1996 Sep; 26(1):29-33. PubMed ID: 8950526
[TBL] [Abstract][Full Text] [Related]
6. Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.
Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Apr; 42(4):953-5. PubMed ID: 9559819
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
Chen YH; Peng CF; Lu PL; Tsai JJ; Chen TP
Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466
[TBL] [Abstract][Full Text] [Related]
8. Is levofloxacin as active as ciprofloxacin against Pseudomonas aeruginosa?
Bonfiglio G
Chemotherapy; 2001; 47(4):239-42. PubMed ID: 11399859
[TBL] [Abstract][Full Text] [Related]
9. Italian survey on comparative levofloxacin susceptibility in 334 clinical isolates of Pseudomonas aeruginosa.
Segatore B; Setacci D; Perilli M; Franceschini N; De Santis A; Marchetti F; Amicosante G
Antimicrob Agents Chemother; 1999 Feb; 43(2):428-31. PubMed ID: 9925553
[TBL] [Abstract][Full Text] [Related]
10. Survey of antibiotic susceptibility among gram-negative bacilli at a cancer center.
Rolston KV; Elting L; Waguespack S; Ho DH; LeBlanc B; Bodey GP
Chemotherapy; 1996; 42(5):348-53. PubMed ID: 8874974
[TBL] [Abstract][Full Text] [Related]
11. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
Kowalski RP; Pandya AN; Karenchak LM; Romanowski EG; Husted RC; Ritterband DC; Shah MK; Gordon YJ
Ophthalmology; 2001 Oct; 108(10):1826-9. PubMed ID: 11581056
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
Tessier F; Quentin C
Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
[TBL] [Abstract][Full Text] [Related]
13. Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa.
Zhanel GG; Mayer M; Laing N; Adam HJ
Antimicrob Agents Chemother; 2006 Jun; 50(6):2228-30. PubMed ID: 16723591
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia.
Isenberg HD; Alperstein P; France K
Diagn Microbiol Infect Dis; 1999 Feb; 33(2):81-6. PubMed ID: 10091030
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa.
Gerçeker AA; Gürler B
J Antimicrob Chemother; 1995 Oct; 36(4):707-11. PubMed ID: 8591946
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal activity of levofloxacin and ciprofloxacin on clinical isolates of different phenotypes of Pseudomonas aeruginosa.
Segatore B; Setacci D; Perilli M; Franceschini N; Marchetti F; Amicosante G
Int J Antimicrob Agents; 2000 Jan; 13(3):223-6. PubMed ID: 10724029
[TBL] [Abstract][Full Text] [Related]
17. Post-antibiotic and synergic effects of fluoroquinolones and ceftazidime in combination against Pseudomonas strains.
Mayer I; Nagy E
Acta Biol Hung; 2001; 52(2-3):241-8. PubMed ID: 11426858
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa.
Bustamante CI; Wharton RC; Wade JC
Antimicrob Agents Chemother; 1990 Sep; 34(9):1814-5. PubMed ID: 2126693
[TBL] [Abstract][Full Text] [Related]
19. Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!
Jones RN; Beach ML; Pfaller MA
Diagn Microbiol Infect Dis; 2001 Nov; 41(3):161-3. PubMed ID: 11750171
[TBL] [Abstract][Full Text] [Related]
20. Synergistic potential of ceftazidime plus amikacin or levofloxacin against Pseudomonas aeruginosa as determined using a checkerboard and a disk diffusion technique.
Montanari MP; Piccoli L; Mingoia M; Marchetti F; Varaldo PE
Diagn Microbiol Infect Dis; 2005 Oct; 53(2):157-60. PubMed ID: 16168614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
